Beauty Health (SKIN)
(Delayed Data from NSDQ)
$2.74 USD
-0.03 (-1.08%)
Updated May 17, 2024 04:00 PM ET
After-Market: $2.74 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth A Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
SKIN 2.74 -0.03(-1.08%)
Will SKIN be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for SKIN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SKIN
Here's What Key Metrics Tell Us About Beauty Health (SKIN) Q1 Earnings
The Beauty Health Company (SKIN) Reports Q1 Loss, Tops Revenue Estimates
SKIN: What are Zacks experts saying now?
Zacks Private Portfolio Services
McKesson (MCK) Q4 Earnings and Revenues Lag Estimates
Compared to Estimates, The Beauty Health Company (SKIN) Q4 Earnings: A Look at Key Metrics
LifeMD, Inc. (LFMD) Reports Q4 Loss, Tops Revenue Estimates
Other News for SKIN
The Beauty Health Company Q1 2024 Earnings: Sitting Pretty Or Turning Ugly?
Beauty Health (SKIN) Receives a Buy from D.A. Davidson
Beauty Health price target lowered by $1 at TD Cowen, here's why
NVAX, GRPN and MVIS among mid-day movers
Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session